Signed a Supply Agreement for High-end Peptide Intermediates with Pfizer Inc. (USA): Provided Fmoc-protected amino acids and peptide coupling intermediates for Pfizer's oncology drug production, with an annual supply volume of 1,500 tons and a contract value of 42 million US dollars.
Signed a Customized Chiral Intermediate Agreement with Germany's Merck Group: Supplied enantiopure (R)-phenylglycinol and (S)-lactic acid derivatives for Merck's cardiovascular drug production, with an annual supply volume of 3,800 tons and a contract value of 28 million US dollars.
Signed a Long-term Supply Agreement for Pyridine Intermediates with India's Sun Pharmaceutical: Tailored to the needs of Sun Pharma's anti-infective drug production, supplied high-purity 2-chloropyridine and 3-aminopyridine with an annual supply volume of 2,500 tons and a contract value of 15 million US dollars.
